Market Overview

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

22.20 +0.17 (0.77%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/15/18MizuhoUpgradesBuy
4/06/18MizuhoUpgradesNeutral
3/05/18Deutsche BankUpgradesBuy
1/24/18Goldman SachsInitiates Coverage OnSell18.0
12/14/17JP MorganDowngradesUnderweight
11/16/17Deutsche BankMaintainsHold18.0
11/13/17BMO CapitalMaintainsMarket Perform17.0
7/17/17Deutsche BankMaintainsHold19.0
6/16/17Cantor FitzgeraldInitiates Coverage OnOverweight18.0
12/15/16Morgan StanleyDowngradesEqual-Weight17.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter